Nasonex 24HR Allergy FDA Approval History
FDA Approved: Yes (First approved March 17, 2022)
Brand name: Nasonex 24HR Allergy
Generic name: mometasone furoate monohydrate
Dosage form: Nasal Spray
Company: Perrigo Company
Treatment for: Allergic Rhinitis
Nasonex 24HR Allergy (mometasone furoate monohydrate) is a corticosteroid nasal spray available over-the-counter for the temporary relief of the symptoms of hayfever or other upper respiratory allergies.
- Perrigo expects to begin offering Nasonex 24HR Allergy later in 2022.
Development timeline for Nasonex 24HR Allergy
| Date | Article |
|---|---|
| Mar 17, 2022 | Approval FDA Approves Nasonex 24HR Allergy (mometasone furoate) Nasal Spray for OTC Use |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.